Abstract

BackgroundCentral diabetes insipidus (CDI) results from a number of conditions affecting the hypothalamic-neurohypophyseal system to cause vasopressin deficiency. Diagnosis of CDI is challenging, and clinical data and guidelines for management are lacking. We aim to characterize clinical and radiological characteristics of a cohort of pediatric patients with CDI.MethodsA chart review of 35 patients with CDI followed at North Carolina Children’s Hospital from 2000 to 2015 was undertaken. The frequencies of specific etiologies of CDI and characteristic magnetic resonance imaging (MRI) findings were determined. The presence of additional hormone deficiencies at diagnosis and later in the disease course was ascertained. Patient characteristics and management strategies were evaluated.ResultsThe cohort included 14 female and 21 male patients with a median age of 4.7 years (range, less than 1 month to 16 years) at diagnosis. Median duration of follow-up was 5 years (range, 2 months to 16 years). The cause of CDI was intracranial mass in 13 patients (37.2 %), septo-optic dysplasia in 9 patients (25.7 %), holoprosencephaly in 5 patients (14.2 %), Langerhans cell histiocytosis in 3 patients (8.6 %), isolated pituitary hypoplasia in 2 patients (5.7 %), and encephalocele in 1 patient (2.9 %). Patients were symptomatic for a mean of 6.3 months (range, less than 1 month to 36 months) prior to diagnosis of CDI. Growth hormone (GH), thyrotropin (TSH), adrenocorticotropic hormone (ACTH), and gonadotropin deficiencies were present at diagnosis in 34, 23, 23, and 6 % of patients, respectively. GH, TSH, ACTH, and gonadotropin deficiencies were diagnosed during follow-up in 23, 40, 37, and 14 % of patients, respectively. In patients with structural CNS abnormalities, development of additional hormone deficiencies occurred anywhere from 2 months to 13 years after the time of initial presentation.ConclusionsAll patients in our cohort had an underlying organic etiology for CDI, with intracranial masses and CNS malformations being most common. Therefore, MRI of the brain is indicated in all pediatric patients with CDI. Other pituitary hormone deficiencies should be investigated at diagnosis as well as during follow-up.

Highlights

  • Central diabetes insipidus (CDI) results from a number of conditions affecting the hypothalamicneurohypophyseal system to cause vasopressin deficiency

  • Our findings are consistent with a recent study by Werny at al [4] that reports a higher prevalence of central nervous system (CNS) malformations in patients with CDI than previously reported, as well as fewer idiopathic cases

  • We identified tumors or Langerhans cell histiocytosis (LCH) in nearly half (46 %) of our patients with CDI, which is similar to the rate of tumors and infiltrative processes (56 %) found by Werny et al [4]

Read more

Summary

Introduction

Central diabetes insipidus (CDI) results from a number of conditions affecting the hypothalamicneurohypophyseal system to cause vasopressin deficiency. We aim to characterize clinical and radiological characteristics of a cohort of pediatric patients with CDI. Central diabetes insipidus (CDI) is characterized by polyuria, polydipsia, and the inability to concentrate urine as a result of arginine vasopressin deficiency. Maintenance of normal tonicity of extracellular fluids is vital to cellular function and is regulated by the complex interaction of fluid intake, vasopressin secretion, and urine output. Vasopressin is synthesized by neurons of the hypothalamic paraventricular and supraoptic nuclei and secreted by the posterior pituitary gland [1]. Malformation or damage to midline cerebral and cranial structures may result in the absence of vasopressin production or secretion. Genetic mutations resulting in abnormal synthesis of vasopressin precursor hormones

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call